- Home
- ->
- Industry News
Oct 27, 2022: "Pharmacists have a baseline understanding of biosimilars that enables them to address, and in many cases overcome prescriber hesitancy. Having pharmacists [with] this influence in these clinic spaces is really significant.”
Outside link:
“Pharmacists are really well positioned to help take ownership of the process and successfully navigate biosimilar implementation and adoption from beginning to end.”